默沙东12月5日交流纪要

文章预览

Geoff Meacham - Citi - Analyst So, Rob, let's just kick it off, maybe bigger picture we had, Scott Gottlieb here yesterday, we're talking about, potential policy changes, IRA, et cetera, give us your perspective on kind of what we may or may not expect looking into the next year. I realize that it's obviously pretty early in the -- Robert Davis - Merck & Co Inc - Chairman of the Board, President, Chief Executive Officer Yeah. Sure. No, so as we look forward with the new administration, with the Trump administration coming in, I would say, first and foremost, we're very much focused on how can we work with administration to improve overall focus on the ecosystem innovation we bring, the value of the industry, the jobs we create and to drive for, improved health for patients. So I think there's a lot we have in common with the administration around that. Clearly, the ability to focus on chronic diseases is something as an industry we've long been talking about understanding both from p ………………………………